Boothbay Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Boothbay Fund Management's VRTX Position: Q2 2026 in Review
Boothbay Fund Management increased its Vertex Pharmaceuticals (VRTX) stake by 368% in Q2 2026, buying an estimated $2.15M and bringing the position to 6,174 shares worth $3.07M. The position accounts for 0.04% of the portfolio, ranked #523.
Boothbay Fund Management first reported a position in VRTX in Q1 2017 and has held it in 17 quarters since. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Boothbay Fund Management held 6,174 shares of Vertex Pharmaceuticals worth $3.07M as of Q2 2026.
- Boothbay Fund Management bought 4,854 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.15M.
- Vertex Pharmaceuticals made up 0.04% of Boothbay Fund Management's portfolio in Q2 2026, its #523 holding.
- Boothbay Fund Management first reported a position in Vertex Pharmaceuticals in Q1 2017 and has held it in 17 quarters since.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.